Related Experiment Video

Updated: May 3, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

8.4K

Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease

A Garfagnini1, G Devoto, P Rosselli

  • 1Servizio di Cardiologia e Unità Coronarica, Ospedale Civile di Lavagna GE, Italy.

European Heart Journal
|April 1, 1995
PubMed

Insights

Apolipoprotein A1 (ApoA1) and its ratio to ApoB better identify severe coronary artery damage in acute myocardial infarction patients than HDL-cholesterol. This finding aids in assessing coronary severity post-heart attack.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Medical Diagnostics

Background:

  • Assessing coronary artery disease severity is crucial for managing patients post-acute myocardial infarction (AMI).
  • Traditional lipid markers like HDL-cholesterol may not fully capture the extent of coronary vessel damage.
  • Apolipoprotein A1 (ApoA1) is a key component of HDL and may offer superior insights.

Purpose of the Study:

  • To compare the efficacy of apolipoprotein A1 (ApoA1) versus HDL-cholesterol in identifying severe coronary vessel damage in AMI patients.
  • To evaluate the diagnostic performance of ApoA1 and the ApoA1/ApoB ratio (A1/B) in assessing coronary atherosclerosis severity.

Main Methods:

  • Study included 141 male patients with recent AMI undergoing coronary angiography.
  • Coronary angiography data were analyzed anatomically and using the Gensini score.
  • Lipid parameters, including ApoA1, ApoB, and HDL-cholesterol, were measured on admission.

Main Results:

  • ApoA1 and A1/B showed significant differences based on HDL-cholesterol cut-offs and Gensini score categories.
  • The ApoA1/ApoB ratio effectively discriminated between different Gensini score groups (<=18 vs. >18).
  • ApoA1 and A1/B levels differed significantly between single-vessel and multi-vessel disease groups, with A1/B distinguishing single from double-vessel disease.

Conclusions:

  • Apolipoprotein A1 (ApoA1) and the ApoA1/ApoB ratio (A1/B) are superior to HDL-cholesterol in assessing the severity of coronary artery damage in AMI patients.
  • These findings suggest ApoA1 and A1/B are valuable biomarkers for evaluating coronary atherosclerosis extent.
  • The study highlights the potential of ApoA1-based markers for improved patient risk stratification after myocardial infarction.
Abstract

More Related Videos

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.6K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

564

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741